피부과용 영상 진단 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 모달리티별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Diagnostic Dermatology Imaging Devices Market was valued at USD 5.13 Billion in 2024 and is projected to reach USD 8.91 Billion by 2030, registering a CAGR of 9.62%. Market growth is being propelled by the increasing prevalence of skin conditions and the need for accurate, early, and non-invasive diagnostic tools. With skin cancer, especially melanoma, posing a growing global health threat, there is heightened demand for advanced imaging technologies that support early detection and effective management. Rising patient awareness regarding regular skin evaluations is also prompting healthcare providers to adopt innovative diagnostic equipment. In addition, an aging population and lifestyle-related skin disorders such as acne, eczema, and psoriasis are driving further demand. A major trend shaping the market is the integration of artificial intelligence (AI) and machine learning into dermatology platforms, enabling automated analysis and enhanced diagnostic precision. The growing popularity of mobile, AI-enabled, and cloud-based imaging systems is improving accessibility, streamlining diagnosis, and fostering remote care capabilities in dermatology practices.

Key Market Drivers

Rising Incidence of Skin Disorders and Skin Cancer

The growing global incidence of skin disorders and skin cancer is a major driver for the increased use of diagnostic dermatology imaging devices. In the United States alone, skin cancer remains the most commonly diagnosed cancer, with an estimated 5.4 million cases reported annually. CDC data further highlights that more than 6.1 million adults are treated each year for basal and squamous cell carcinomas, incurring nearly USD 8.9 billion in treatment costs. Melanoma, while less prevalent, is notably aggressive, with approximately 200,340 cases projected in 2024, including 99,700 in situ and 100,640 invasive cases. Traditional assessment methods-such as manual examination-lack the depth and precision required for early detection. Devices like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography provide non-invasive, real-time, cellular-level imaging, enhancing diagnostic accuracy and enabling earlier intervention. This contributes to significantly improved survival outcomes, as early-stage melanoma carries a five-year relative survival rate exceeding 94%.

Key Market Challenges

High Cost of Advanced Imaging Systems

The elevated cost of advanced imaging systems presents a significant obstacle to the broader adoption of diagnostic dermatology devices. Technologies such as high-resolution digital dermatoscopes, reflectance confocal microscopes, and optical coherence tomography scanners involve substantial initial investment. Smaller healthcare providers and facilities in under-resourced areas often struggle with the financial burden of procuring, maintaining, and upgrading this equipment. Additionally, ongoing expenses related to software updates, technical servicing, and clinician training further strain budgets. These financial limitations restrict the availability of advanced diagnostic tools in rural or low-income regions, thereby impeding timely diagnosis and treatment for underserved populations.

Key Market Trends

Growth of Teledermatology and Remote Diagnostics

A key trend reshaping the Global Diagnostic Dermatology Imaging Devices Market is the growing emphasis on teledermatology and remote diagnostic capabilities. The need for accessible skin healthcare in rural and underserved areas has spurred the development of compact, cloud-enabled imaging tools that facilitate real-time skin assessments and virtual consultations. These platforms allow patients to securely send high-resolution images of skin lesions to dermatologists, enabling remote analysis and timely diagnosis. This model improves convenience for patients and enhances dermatologists' efficiency by streamlining triage and reducing the need for in-person visits. Rising smartphone use and broader internet access further support the adoption of mobile imaging technologies, making them valuable instruments in expanding early diagnostic coverage.

Report Scope:

In this report, the Global Diagnostic Dermatology Imaging Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Dermatology Imaging Devices Market, By Modality:

• Advanced Diagnostic Imaging Devices
• Surface Visualization Devices
• Biopsy Devices
• Molecular Diagnostic Devices & Platforms

Diagnostic Dermatology Imaging Devices Market, By Application:

• Skin Cancer
• Inflammatory & Autoimmune Skin Diseases
• Infectious Skin Conditions
• Wound & Ulcer Assessment

Diagnostic Dermatology Imaging Devices Market, By End User:

• Hospitals
• Dermatology Clinics/Centers
• Cancer Centers/Oncology Clinics
• Others

Diagnostic Dermatology Imaging Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Dermatology Imaging Devices Market.

Available Customizations:

Global Diagnostic Dermatology Imaging Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Diagnostic Dermatology Imaging Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Modality (Advanced Diagnostic Imaging Devices, Surface Visualization Devices, Biopsy Devices, Molecular Diagnostic Devices & Platforms)
  • 5.2.2. By Application (Skin Cancer, Inflammatory & Autoimmune Skin Diseases, Infectious Skin Conditions, Wound & Ulcer Assessment)
  • 5.2.3. By End User (Hospitals, Dermatology Clinics/Centers, Cancer Centers/Oncology Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Diagnostic Dermatology Imaging Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Modality
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Modality
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Modality
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Modality
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Diagnostic Dermatology Imaging Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Modality
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Modality
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Modality
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Modality
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Modality
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Modality
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Diagnostic Dermatology Imaging Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Modality
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Modality
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Modality
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Modality
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Modality
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Modality
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Diagnostic Dermatology Imaging Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Modality
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Modality
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Modality
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Modality
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Diagnostic Dermatology Imaging Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Modality
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Modality
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Modality
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Modality
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Canfield Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Caliber Imaging & Diagnostics
• 15.3. Michelson Diagnostics (MDL)
• 15.4. SciBase AB
• 15.5. DermaSensor Inc.
• 15.6. Damae Medical
• 15.7. Apollo Medical Optics
• 15.8. Enspectra Health, Inc.
• 15.9. Dermavision Solutions
• 15.10. Dermus Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer